GLYCOBIDUO Trademark

Trademark Overview


On Thursday, May 1, 2025, a trademark application was filed for GLYCOBIDUO with the United States Patent and Trademark Office. The USPTO has given the GLYCOBIDUO trademark a serial number of 99166457. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, August 12, 2025. This trademark is owned by OBI PHARMA, INC.. The GLYCOBIDUO trademark is filed in the Pharmaceutical Products category with the following description:

Immunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer to be treated; Preparations of microorga...
glycobiduo

General Information


Serial Number99166457
Word MarkGLYCOBIDUO
Filing DateThursday, May 1, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, August 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 2, 2025

Trademark Statements


Description of MarkThe mark consists of the stylized wording "GLYC OBI DUO". The wording "GLYC" and "DUO" are in black and "OBI" is in teal. There is a curved teal line below "OBI". The color white represents background, outlining, shading and/or transparent areas and is not part of the mark.
Goods and ServicesImmunostimulants; Chemical reagents for medical or veterinary purposes; Enzymes for medical purposes; Vaccines; Hormones for medical purposes; Adjuvants for medical purposes; Ferments for pharmaceutical purposes; Enzyme preparations for medical purposes; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for use in chemotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer to be prevented or treated; Pharmaceutical preparations for the treatment and prevention of cancer to be treated; Preparations of microorganisms for medical purposes
Indication of Colors claimedThe color(s) black and teal is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 1, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOBI PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 115011
TW

Trademark Events


Event DateEvent Description
Thursday, May 1, 2025NEW APPLICATION ENTERED
Thursday, May 1, 2025APPLICATION FILING RECEIPT MAILED
Monday, June 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 8, 2025ASSIGNED TO EXAMINER
Monday, July 28, 2025EXAMINER'S AMENDMENT ENTERED
Monday, July 28, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 28, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, July 28, 2025EXAMINERS AMENDMENT E-MAILED